Serum Institute

New Delhi: Serum Institute of India (SII) has got the go-ahead from Drugs Controller General of India (DCGI) to manufacture Russian-developed Sputnik vaccine in India. “The DCGI has…

Pune: Now, Serum Institute of India (SII) wants to manufacture COVID-19 vaccine Sputnik V. The Pune-based company has already applied to the Drugs Controller General of India (DCGI)…

Pune: Serum Institute of India (SII) got into damage control mode after one of its senior officials criticized the Centre’s vaccination policy. The world’s largest vaccine maker clarified…

After the Centre rubbished media reports saying that it had not placed fresh orders for COVID-19 vaccines, Serum Institute of India (SII) CEO Adar Poonawalla also clarified they have…

New Delhi: The price of Covishield has been reduced from Rs 400 to Rs 300 per dose for all states and union territories, which can acquire the vaccine directly from Serum Institute of India…

Colombo: Sri Lanka has decided to put China’s Sinopharm COVID-19 vaccine on hold and use India’s Serum Institute of India (SII)-manufactured Oxford-AstraZeneca vaccine Covishield to…

New Delhi: Serum Institute of India (SII) got the approval to conduct Phase 2 and 3 clinical trials for Novavax’s COVID-19 vaccine candidate in the country. The green signal came from…

Pune: The government of India has placed an order with Serum Institute of India (SII) to supply 11 million doses of Covishield vaccine at Rs 200 each. Eight days after the Drugs…

Pune: India will not allow the Oxford University-AstraZeneca coronavirus vaccine’s export for several months, according to Serum Institute of India (SII) CEO Adar Poonawalla. SII has been…

New Delhi: The Drug Controller General of India (DCGI) is likely to allow the emergency use of the Covishield vaccine in India without the necessary approval from the UK where it was…